BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22167082)

  • 1. [Regenerative therapy for tendon and ligament disorders in horses. Terminology, production, biologic potential and in vitro effects].
    Geburek F; Stadler P
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2011; 39(6):373-83. PubMed ID: 22167082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
    Romero A; Barrachina L; Ranera B; Remacha AR; Moreno B; de Blas I; Sanz A; Vázquez FJ; Vitoria A; Junquera C; Zaragoza P; Rodellar C
    Vet J; 2017 Jun; 224():76-84. PubMed ID: 28697880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein.
    Textor J
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):275-98. PubMed ID: 21872759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.
    Caniglia CJ; Schramme MC; Smith RK
    Equine Vet J; 2012 Sep; 44(5):587-93. PubMed ID: 22150794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study.
    Bosch G; van Schie HT; de Groot MW; Cadby JA; van de Lest CH; Barneveld A; van Weeren PR
    J Orthop Res; 2010 Feb; 28(2):211-7. PubMed ID: 19714688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
    Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
    Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells for tendon and ligament tissue engineering and regeneration.
    Siddiqui NA; Wong JM; Khan WS; Hazlerigg A
    J Stem Cells; 2010; 5(4):187-94. PubMed ID: 22314867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and Development Symposium: Stem cell therapy in equine tendon injury.
    Reed SA; Leahy ER
    J Anim Sci; 2013 Jan; 91(1):59-65. PubMed ID: 23100589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary report on regenerative healing in the equine tendon.
    Norrie RD
    Am J Vet Res; 1975 Oct; 36(10):1523-4. PubMed ID: 1081355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the use of growth factors for treatment of disorders of soft tissues.
    Halper J
    Adv Exp Med Biol; 2014; 802():59-76. PubMed ID: 24443021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions.
    Bosch G; Moleman M; Barneveld A; van Weeren PR; van Schie HT
    Scand J Med Sci Sports; 2011 Aug; 21(4):554-61. PubMed ID: 20459479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses.
    Marfe G; Rotta G; De Martino L; Tafani M; Fiorito F; Di Stefano C; Polettini M; Ranalli M; Russo MA; Gambacurta A
    Life Sci; 2012 Jun; 90(21-22):825-30. PubMed ID: 22480518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based therapies for tendon and ligament injuries.
    Alves AG; Stewart AA; Dudhia J; Kasashima Y; Goodship AE; Smith RK
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):315-33. PubMed ID: 21872761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative Medicine and Rehabilitation for Tendinous and Ligamentous Injuries in Sport Horses.
    Ortved KF
    Vet Clin North Am Equine Pract; 2018 Aug; 34(2):359-373. PubMed ID: 29803299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells.
    Sahoo S; Toh SL; Goh JC
    Biomaterials; 2010 Apr; 31(11):2990-8. PubMed ID: 20089300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-rich plasma treatment for ligament and tendon injuries.
    Paoloni J; De Vos RJ; Hamilton B; Murrell GA; Orchard J
    Clin J Sport Med; 2011 Jan; 21(1):37-45. PubMed ID: 21200169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerative Approaches to Tendon and Ligament Conditions.
    Brown MN; Shiple BJ; Scarpone M
    Phys Med Rehabil Clin N Am; 2016 Nov; 27(4):941-984. PubMed ID: 27788909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of platelet rich plasma and acellular bone marrow on gene expression patterns and DNA content of equine suspensory ligament explant cultures.
    Schnabel LV; Sonea HO; Jacobson MS; Fortier LA
    Equine Vet J; 2008 May; 40(3):260-5. PubMed ID: 18267879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.
    Guest DJ; Smith MR; Allen WR
    Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative medicine for the treatment of Teno-desmic injuries of the equine. A series of 150 horses treated with platelet-derived growth factors.
    Scala M; Lenarduzzi S; Spagnolo F; Trapasso M; Ottonello C; Muraglia A; Barla A; Squillario M; Strada P
    In Vivo; 2014; 28(6):1119-23. PubMed ID: 25398809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.